Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013

Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patients who lived inMoscow in 1993, 1998, 2003, 2008,...

Full description

Bibliographic Details
Main Authors: N. Yu. Kashirskaya, S. A. Krasovsky, A. V. Chernyak, V. D. Sherman, A. Yu. Voronkova, L. A. Shabalova, V. S. Nikonova, Yu. V. Gorinova, O. I. Simonova, E. L. Amelina, E. I. Kondrat’eva, N. I. Kapranov, N. V. Petrova, R. A. Zinchenko
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2015-09-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/1083
_version_ 1797694932715044864
author N. Yu. Kashirskaya
S. A. Krasovsky
A. V. Chernyak
V. D. Sherman
A. Yu. Voronkova
L. A. Shabalova
V. S. Nikonova
Yu. V. Gorinova
O. I. Simonova
E. L. Amelina
E. I. Kondrat’eva
N. I. Kapranov
N. V. Petrova
R. A. Zinchenko
author_facet N. Yu. Kashirskaya
S. A. Krasovsky
A. V. Chernyak
V. D. Sherman
A. Yu. Voronkova
L. A. Shabalova
V. S. Nikonova
Yu. V. Gorinova
O. I. Simonova
E. L. Amelina
E. I. Kondrat’eva
N. I. Kapranov
N. V. Petrova
R. A. Zinchenko
author_sort N. Yu. Kashirskaya
collection DOAJ
description Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patients who lived inMoscow in 1993, 1998, 2003, 2008, and 2013. It was found that the survival rate of these patients depended on the choice of drug therapy (pancreatic enzymes, dornase alfa, intravenous and inhaled antipseudomonal antibiotics), changes in diet, active dispensary observation at a specialized center for cystic fibrosis, and neonatal screening. We determined the cost of drug therapy per patient. From 1993 to 2013, the survival rate of patients who lived in Moscow increased by more than 20 years (from 16 to 39 years, respectively). The average cost of therapy increased more than 10 times (from USD 1.8 to 21.9 thousand, respectively).
first_indexed 2024-03-12T03:05:01Z
format Article
id doaj.art-469ac005c5ab44a3b76219cbd0d47e2f
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T03:05:01Z
publishDate 2015-09-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-469ac005c5ab44a3b76219cbd0d47e2f2023-09-03T14:32:58Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352015-09-0114450350810.15690/vsp.v14.i4.13901084Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013N. Yu. Kashirskaya0S. A. Krasovsky1A. V. Chernyak2V. D. Sherman3A. Yu. Voronkova4L. A. Shabalova5V. S. Nikonova6Yu. V. Gorinova7O. I. Simonova8E. L. Amelina9E. I. Kondrat’eva10N. I. Kapranov11N. V. Petrova12R. A. Zinchenko13Медико-генетический научный центр, Москва, Российская ФедерацияНИИ пульмонологии, Москва, Российская ФедерацияНИИ пульмонологии, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияНаучный центр здоровья детей, Москва, Российская ФедерацияНаучный центр здоровья детей, Москва, Российская ФедерацияНИИ пульмонологии, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская ФедерацияМедико-генетический научный центр, Москва, Российская Федерация Московский государственный медико-стоматологический университет им. А.И. Евдокимова, Москва, Российская ФедерацияCystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patients who lived inMoscow in 1993, 1998, 2003, 2008, and 2013. It was found that the survival rate of these patients depended on the choice of drug therapy (pancreatic enzymes, dornase alfa, intravenous and inhaled antipseudomonal antibiotics), changes in diet, active dispensary observation at a specialized center for cystic fibrosis, and neonatal screening. We determined the cost of drug therapy per patient. From 1993 to 2013, the survival rate of patients who lived in Moscow increased by more than 20 years (from 16 to 39 years, respectively). The average cost of therapy increased more than 10 times (from USD 1.8 to 21.9 thousand, respectively).https://vsp.spr-journal.ru/jour/article/view/1083муковисцидозвыживаемостьлечениестоимостьдорназа альфа
spellingShingle N. Yu. Kashirskaya
S. A. Krasovsky
A. V. Chernyak
V. D. Sherman
A. Yu. Voronkova
L. A. Shabalova
V. S. Nikonova
Yu. V. Gorinova
O. I. Simonova
E. L. Amelina
E. I. Kondrat’eva
N. I. Kapranov
N. V. Petrova
R. A. Zinchenko
Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
Вопросы современной педиатрии
муковисцидоз
выживаемость
лечение
стоимость
дорназа альфа
title Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
title_full Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
title_fullStr Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
title_full_unstemmed Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
title_short Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
title_sort trends in life expectancy of cystic fibrosis patients in moscow and their connection with the treatment received retrospective analysis for 1993 2013
topic муковисцидоз
выживаемость
лечение
стоимость
дорназа альфа
url https://vsp.spr-journal.ru/jour/article/view/1083
work_keys_str_mv AT nyukashirskaya trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT sakrasovsky trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT avchernyak trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT vdsherman trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT ayuvoronkova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT lashabalova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT vsnikonova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT yuvgorinova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT oisimonova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT elamelina trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT eikondrateva trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT nikapranov trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT nvpetrova trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013
AT razinchenko trendsinlifeexpectancyofcysticfibrosispatientsinmoscowandtheirconnectionwiththetreatmentreceivedretrospectiveanalysisfor19932013